Literature DB >> 3182454

Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.

H K van Saene1, S E Lemmens, J J van Saene.   

Abstract

The selectivity of enterobacterial decontamination during oral ofloxacin and ciprofloxacin was studied in 15 volunteers. Dilution studies of 294 faecal samples were made to monitor concentrations of enterobacteria, yeasts and enterococci. Detection of beta-aspartylglycine content was used for evaluation of interaction with the indigenous (mostly anaerobic) flora. Inactivation of ofloxacin and ciprofloxacin by faeces was studied to explain the effects of gut decontamination. Escherichia coli was successfully eliminated from the gut in all volunteers during treatment. Decontamination was found to be more or less selective with both quinolones, although yeast overgrowth and decrease of enterococci was significantly higher with ciprofloxacin. This may be explained by the higher intrinsic activity of ciprofloxacin against anaerobic flora, the inactivation by faeces being low for both agents. Ofloxacin and ciprofloxacin are two new quinolones of value in the therapy of infections between 'waist and knee' (e.g. cystitis, enteritis, prostatitis) because of the elimination of the infection focus combined with the eradication of the source.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182454     DOI: 10.1093/jac/22.supplement_c.127

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients.

Authors:  H U Krüger; U Schuler; B Proksch; M Göbel; G Ehninger
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review.

Authors:  Gabor S A Abis; Hein B A C Stockmann; Marjolein van Egmond; Hendrik J Bonjer; Christina M J E Vandenbroucke-Grauls; Steven J Oosterling
Journal:  J Gastrointest Surg       Date:  2013-10-11       Impact factor: 3.452

Review 4.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

7.  Selective decontamination of the colon before elective colorectal surgery. West of Scotland Surgical Infection Study Group.

Authors:  E W Taylor; G Lindsay
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

8.  Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.

Authors:  Miranda W Langendam; Edine W Tiemersma; Marieke J van der Werf; Andreas Sandgren
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.